Back

Serum levels of fetal tenascin-C variants as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction in pulmonary hypertension

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Pulmonary hypertension, congenital and acquired Chronic pulmonary hypertension ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Marcus Franz

Cardiovascular Center Rotenburg an der Fulda, Rotenburg an der Fulda (Germany)

8 More presentations in this session

Presentation thumbnail
Simplicity denervation system for pulmonary artery denervation in patients with pulmonary hypertension (first-in-man study)
Doctor B. Rudenko (Moscow, RU)
Abstract Slides
Presentation thumbnail
Prediction of pulmonary hypertension long-term after atrial septal defect closure
Ms R. Zwijnenburg (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Superior performance of ePLAR (echocardiographic Pulmonary to Left Atrial Ratio) in the diagnosis of sub-massive acute pulmonary emboli compared with traditional echocardiographic parameters.
Professor G. Scalia (Brisbane, AU)
Abstract
Presentation thumbnail
Predictors of pulmonary artery hypertension recovery after Trans Aortic Valve Implantation
Mr H. Chopra (Paris, FR)
Abstract Slides
Presentation thumbnail
Heart rate variability predicts pulmonary artery pressures in experimental pulmonary arterial hypertension in the rat
Doctor C. Schreiber (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 6 - Pulmonary hypertension, congenital and acquired

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources